Regulation - Merck & Co

Filter

Current filters:

Merck & Co

Popular Filters

76 to 82 of 82 results

FDA panel gives unanimous backing for Merck & Co’s Vytorin for some kidney disease patients

04-11-2011

US drug giant Merck & Co (NYSE: MRK) said yesterday that the Endocrinologic and Metabolic Drugs Advisory…

Cardio-vascularMerck & CoNorth AmericaPharmaceuticalRegulationVytorin

76 to 82 of 82 results

Back to top